Clik here to view.
QImaging® Launches New optiMOS™ Scientific CMOS Camera
Smart Multimedia Gallery Featuring faster frame rates and lower noise, the optiMOS sCMOS Camera was designed as the higher performance, budget friendly CCD alternative (Photo: Business Wire) View...
View ArticleClik here to view.
BSD Medical Announces First Symposium on Hyperthermia Treatment of Cancer in...
SALT LAKE CITY BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the...
View ArticleClik here to view.
HOYA Group to Set up a Joint Venture with Wassenburg Medical Devices in the...
TOKYO HOYA (TOKYO:7741) today announced that it has signed an agreement to acquire a majority shareholding in Wassenburg Group, an Automated Endoscope Reprocessing (AER) market leader in the...
View ArticleClik here to view.
HOYAグループ：内視鏡分野でWassenburg Medical Devices社とのジョイントベンチャーを開始
東京 （ビジネスワイヤ） — HOYAグループはこのたび、オランダの自動内視鏡洗浄装置（AER）のマーケットリーダーであるWassenburg & CO BV（ワッセンバーグ社、以下Wassenburg社）の過半数株式を取得する契約を締結したことを発表しました。クロージング予定日は11月1日です。 医療用軟性内視鏡の製造・販売を手掛けるHOYAグループPENTAX...
View ArticleClik here to view.
亞裔及非亞裔次族群研究數據分析顯示 不可逆標靶藥物 (afatinib) 能夠提供患者更好的療效及安全性
德國殷格翰 (美國商業資訊)–僅供美國以外媒體 兩個供新藥查驗登記之大型第三期臨床研究 (LUX-Lung 3 及 LUX-Lung 6) 皆證實：不可逆標靶藥物 (afatinib) 對於亞洲人或非亞洲人的治療效果皆比化療更優越，而其副作用亦是能被妥善控制的2,3。新的次族群分析報告證實，無論為亞裔或非亞裔人種，不可逆標靶藥物 (afatinib) 都能夠安全的治療具有表皮生長因子...
View ArticleClik here to view.
Takeda Announces More than 370 Abstracts on VELCADE® (bortezomib), ADCETRIS®...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) today announced 370 abstracts, involving five molecules in the company’s portfolio, have been accepted for presentation at this year’s...
View ArticleClik here to view.
Pieris Receives Third Milestone Payment in Daiichi Sankyo Collaboration to...
FREISING, Germany Pieris AG has achieved its third milestone overall in its discovery and development collaboration with Daiichi Sankyo Company Limited (hereinafter Daiichi Sankyo; headquartered in...
View ArticleClik here to view.
CORRECTING and REPLACING Takeda Announces 118 Abstracts on VELCADE®...
OSAKA, Japan Please replace the release dated November 11, 2013 with the following correction version due to multiple revisions. The corrected release reads: TAKEDA ANNOUNCES 118 ABSTRACTS ON...
View ArticleClik here to view.
エリテックが急性骨髄性白血病における第IIb相試験の肯定的なDSMB評価結果を発表
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的治療薬の開発に当たっているフランスのバイオ製薬企業エリテック（Paris:ERYP）（NYSE Euronext Paris: FR0011471135 –...
View ArticleClik here to view.
Cisbio Bioassays, in Partnership with Argos Soditic, Makes a Major Step...
PARIS & CODOLET, France The funds managed by Argos Soditic announce the acquisition, together with the management, of Cisbio Bioassays. This cutting-edge biotechnology company is the leader in...
View ArticleClik here to view.
Cisbio Bioassays与Argos Soditic携手合作，迈出向前发展的关键一步
法国巴黎和科多莱 (美国商业资讯)–Argos Soditic管理下的基金宣布与Cisbio Bioassays管理层携手收购Cisbio Bioassays。Cisbio Bioassays是一家尖端生物技术公司，它是体外诊断和制药研究产品及服务领域中的领先企业。 通过这一管理层收购(MBO)操作，Cisbio Bioassays从比利时IBA集团中分拆，成为独立公司。...
View ArticleClik here to view.
シスビオ・バイオアッセイズがアルゴス・ソディティックと共に開発活動を促進
パリ、仏コドレ （ビジネスワイヤ） — アルゴス・ソディティックが運用するファンドは、シスビオ・バイオアッセイズを経営陣と共に買収すると発表しました。シスビオ・バイオアッセイズは最先端のバイオテクノロジー企業であり、ヒト体外診断・薬剤研究分野の大手です。 シスビオ・バイオアッセイズは、このマネジメント・バイアウト（MBO）を通じて独立し、スピンオフとしてベルギーのIBAグループを離れます。...
View ArticleClik here to view.
Agilent Technologies to Collaborate with University of Queensland on Oral...
SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced it will collaborate with the University of Queensland Centre for Clinical Research in Brisbane, Australia, to increase...
View ArticleClik here to view.
ResearchDx, the Leading Contract Diagnostics Organization, Expands Operations...
MUMBAI ResearchDx, LLC of Irvine, California, USA today announced an expansion of its operations to focus on the important Indian biopharmaceutical and diagnostics markets. As part of this...
View ArticleClik here to view.
SillaJen Announces Agreement to Acquire Jennerex, Inc.
BUSAN, South Korea & SAN FRANCISCO SillaJen, Inc., a privately-held biotherapeutics and contract research company focused on the development of targeted biological products for cancer, announced...
View ArticleClik here to view.
Transgene Supports Proposed Acquisition of Jennerex by SillaJen
STRASBOURG, France Regulatory News: Transgene SA (Paris:TNG) (NYSE-Euronext: TNG) said today that it welcomed the announcement by SillaJen, Inc. of its intention to acquire Jennerex, Inc. and has...
View ArticleClik here to view.
PENTAX Medical and SMART Medical Systems Announce Strategic Pan-European...
Smart Multimedia Gallery The G-EYE(TM) endoscope (Photo: Business Wire) View and Share Photo Download Small RA’ANANA, Israel & HAMBURG, Germany SMART Medical Systems Ltd., a developer and...
View ArticleClik here to view.
Sumitomo Proton Therapy System Clears FDA 510(k)
Smart Multimedia Gallery Gantry Treatment System (Photo: Business Wire) View and Share Photo Download Small TOKYO Sumitomo Heavy Industries, Ltd. (TOKYO:6302) announced today that it had received US...
View ArticleClik here to view.
Data from Final Cohort of Patients in Patrys Multiple Myeloma Clinical Trial
MELBOURNE, Australia Patrys Limited (ASX:PAB), a clinical stage biotechnology company has announced that updated results from its PAT-SM6 Phase I/IIa clinical trial in multiple myeloma (MM) will be...
View ArticleClik here to view.
住友重機械：陽子線がん治療装置の米国内販売許可を取得
Smart Multimedia Gallery 回転ガントリー照射装置 （写真：ビジネスワイヤ） View and Share Photo Download Small 東京 （ビジネスワイヤ） — 住友重機械工業株式会社（社長 別川...
View Article